Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma
Jake S. O’Donnell, Stewart Hunt, Keith J. Chappell
The Lancet Haematology (2023) Vol. 10, Iss. 7, pp. e539-e548
Closed Access | Times Cited: 11

Showing 11 citing articles:

Mature T-Cell Neoplasms and Natural Killer-Cell Malignancies
Anne Tierens
Cambridge University Press eBooks (2025), pp. 141-163
Closed Access
HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
Nicolas Tardiota, Noushin Jaberolansar, Julia Lackenby, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Evaluating tocilizumab safety and immunomodulatory effects under ocular HTLV-1 infection in vitro
Jing Zhang, Koju Kamoi, Yuan Zong, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112460-112460
Closed Access | Times Cited: 3
Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
Jake S. O’Donnell, Noushin Jaberolansar, Keith J. Chappell
The Lancet Microbe (2024) Vol. 5, Iss. 4, pp. e400-e408
Open Access | Times Cited: 2
A Comprehensive Review on Unravelling the Complexity of Blood Cancer
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Journal of Pharmaceutical Sciences Review and Research (2024) Vol. 84, Iss. 3
Open Access | Times Cited: 1
Заболевания, ассоциированные с Т-лимфотропным вирусом типа 1 человека (HTLV-1)
Lubov V. Radygina, Larisa V. Mochalova
Microbiology Independent Research Journal (MIR Journal) (2024) Vol. 11, Iss. 1
Open Access
Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States
Junji Yamauchi, Divya Raghavan, Hannah Imlay, et al.
Transplantation Direct (2024) Vol. 10, Iss. 10, pp. e1707-e1707
Open Access
Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity
Yuki Egawa, Tomonori Higuchi, Yumiko Hashida, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Diseases caused by human T-lymphotropic virus type 1 (HTLV-1)
Lubov V. Radygina, Larisa V. Mochalova
Microbiology Independent Research Journal (MIR Journal) (2024) Vol. 11, Iss. 1
Open Access
HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
Nicolas Tardiota, Noushin Jaberolansar, Julia Lackenby, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Unraveling the role of ZNF506 as a human PBS-pro-targeting protein for ERVP repression
Qian Wu, Lu Fang, Yixuan Wang, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 19, pp. 10309-10325
Open Access | Times Cited: 1
Page 1

Scroll to top